Tert-butyl 4-hydroxypiperidine-1-carboxylate → tert-Butyl 4-((4-bromothiazol-2-yl)oxy)piperidine-1-carboxylate
Reaction equation
[OH:1][CH:2]1[CH2:7][CH2:6][N:5]([C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[CH2:4][CH2:3]1.Br[C:16]1[S:17][CH:18]=[C:19]([Br:21])[N:20]=1>>[Br:21][C:19]1[N:20]=[C:16]([O:1][CH:2]2[CH2:3][CH2:4][N:5]([C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[CH2:6][CH2:7]2)[S:17][CH:18]=1Participants
3
Procedure
The title compound was prepared by following the similar procedure as described in Intermediate-42 using tert-butyl 4-hydroxypiperidine-1-carboxylate and 2,4-dibromothiazole (0.1 g, 25%); MS: 363.2 (M+1).
Sources & evidence
- ORD record
- ord-fea8bfd9d6ce458091ba79bbfef08223
- Source dataset
- uspto-grants-2015_04
- Patent number
- US09000175B2
Reaction notes
Loading…